Sarissa Capital Management as of Dec. 31, 2021
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 11 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes SHS (ALKS) | 28.3 | $327M | 14M | 23.26 | |
| Gilead Sciences (GILD) | 18.2 | $210M | 2.9M | 72.61 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 16.5 | $191M | 16M | 11.66 | |
| Biogen Idec (BIIB) | 13.4 | $154M | 643k | 239.92 | |
| Innoviva (INVA) | 9.9 | $114M | 6.6M | 17.25 | |
| Amarin Corp Spons Adr New (AMRN) | 5.6 | $65M | 19M | 3.37 | |
| BioCryst Pharmaceuticals (BCRX) | 4.8 | $56M | 4.0M | 13.85 | |
| Mersana Therapeutics (MRSN) | 2.3 | $27M | 4.3M | 6.22 | |
| Vor Biopharma (VOR) | 0.7 | $8.2M | 707k | 11.62 | |
| Pear Therapeutics Class A Com | 0.3 | $3.1M | 500k | 6.20 | |
| Regulus Therapeutics Com New | 0.1 | $583k | 1.9M | 0.31 |
